Indication

African trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is a vector-borne parasitic infection caused by protozoa of the genus *Trypanosoma*, specifically *Trypanosoma brucei gambiense* or *Trypanosoma brucei rhodesiense*, and transmitted to humans through the bite of infected tsetse flies in sub-Saharan Africa. Read more about African trypanosomiasis

0 drugs 0 manufacturers

Advertisement

Drugs that treat it

Common African trypanosomiasis therapies.

0 drugs

No drugs are available

This indication does not currently contain public drugs.

Filter & compare in the drug finder →Opens the drug finder with African trypanosomiasis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About African trypanosomiasis.

African trypanosomiasis, also known as sleeping sickness, is a vector-borne parasitic infection caused by protozoa of the genus *Trypanosoma*, specifically *Trypanosoma brucei gambiense* or *Trypanosoma brucei rhodesiense*, and transmitted to humans through the bite of infected tsetse flies in sub-Saharan Africa.

The illness progresses through two distinct clinical phases: an initial hemolymphatic stage marked by nonspecific systemic features such as fever, headache, pruritus, and lymphadenopathy, followed by a meningoencephalitic stage as parasites cross the blood-brain barrier into the central nervous system.

This secondary neurologic involvement causes hallmark disruptions in sleep-wake architecture, progressive neurocognitive impairment, sensory disturbances, and motor dysfunction, which typically lead to coma and death if left untreated.

Personalize your experience

Follow African trypanosomiasis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it